Angelito Jonas Kalaw, M.D.

Since joining Parexel in 2010, Angelito has nearly 15 years of experience in the pharmaceutical industry and clinical practice. As Senior Medical Director, he acts as a global lead or regional study physician for both early and late-phase clinical trials, bringing significant experience in pharmacovigilance and medical monitoring.

Angelito is board-certified in adult neurology with a specialization in stroke and neurovascular disease. His therapeutic expertise also encompasses epilepsy, Parkinson’s disease, and dementia as well as psychiatry, particularly schizophrenia, bipolar, and major depressive disorders.